Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics.

[2] In 2005, Meda bought German pharmaceutical brand Viatris GMBH from Advent International for €750million ($926 million).

[3] On 20 July 2007, Meda announced an $800 million cash-and-stock deal to buy the New Jersey–based pharmaceutical company MedPointe from a group of U.S. investors.

MedPointe bought the diagnostics and drug businesses of Carter-Wallace in 2001, with the consumer product line going to Church & Dwight.

[5] In 2014, Meda acquired the Italian firm Rottapharm Madaus in order to add consumer health products to their portfolio.